Izindaba Zenkampani

I-T&L Biotechnology yethula ngokuziqhenya izinsiza eziphelele ze-exosome-Iklanyelwe ukusekela zonke izigaba zohambo lwakho, kusukela ekukhishweni nasekuhlanzweni kuya ku-lyophilization yezinga le-GMP.

🌟 Esikunikezayo:
✔ Ubuchwepheshe obusezingeni eliphezulu bokumisa okomisa izimpushana ezinzile, ezilungele ukusetshenziswa.
✔ Izixazululo zokuhlanzeka okuphezulu ezinokulawulwa kwekhwalithi okuqinile (>95% ubumsulwa).
✔ Ukusekelwa okugcwele kwe-spectrum okuklanyelwe ubuhle, umuthi ovuselelayo, kanye nokuqanjwa kabusha kokwelapha.

Thola ukuthi izixazululo zethu zokuphela-to-ekupheleni zinikeza kanjani amandla abacwaningi namabhizinisi ukuze bavule amandla amakhulu e-exosomes.

💡 Ingabe usukulungele ukuphakamisa iphrojekthi yakho? Hlola okwengeziwe lapha:

Lapho iklayenti sika Nk Cell isiko libhekane nenkinga ebalulekile yokuphila—okuqala ngokusebenza kahle okungama-47% kanye nokungakhuli kahle—Ithimba lochwepheshe be-T&L Biotechnology langenela ngokunemba nangobuchwepheshe. Ezinsukwini eziyi-17 nje, sizuze ukunwetshwa okuphindwe izikhathi ezingama-500 kanye nezinga elihle elingu-90.8%. Nansi indlela esikwenze ngayo.

✅ Izinzuzo Eziyinhloko
✓ I-Bioactivity Ephakeme engu-5x (Igunyazwe ngamaseli e-Mo7e)
✓ Ukuhlanzeka Okuphezulu Okuphezulu >90% (I-SDS-PAGE Iqinisekisiwe)
✓ I-Endotoxin Ephansi

🔬Izinhlelo zokusebenza
▸ Intambo Yegazi HSC Ukunwetshwa
▸ I-In Vitro Drug Screening Platforms
▸ Ucwaningo Lokufeyila Umnkantsha Wamathambo

📊 ​​Amaphuzu avelele edatha
⭐ Ukwenyuka okuphindwe kathathu kwe-CFU nge-SCF/IL-3 Synergy
⭐ Igcina i-HSC Quiescence amahora angama-72+

🚀 Siya eNew Orleans—sokubona endaweni ye-T&L Biotechnology!

Ama-T cell adlala indima ebalulekile esimisweni sethu somzimba sokuzivikela ezifweni, futhi imishanguzo ye-T cell iyagqama ekwelapheni izifo eziyinselele ezinjengomdlavuza kanye nokuphazamiseka kwe-autoimmune. Isinyathelo esibalulekile ku-T I-Cell Therapy,Ukwenziwa kusebenze kwe-T cell, ithinta ngokuqondile imiphumela yokwelapha. Yingakho sikujabulele ukwethula eyethu I-ActCel T Cell Activation Reagent (Cat. No. TL-6001-1000) - Idizayinelwe ukwenziwa kusebenze okuthambile, okuphumelelayo ukusekela ukusebenza kahle kwamaseli nokwanda.

Izici Eziyinhloko
✔️ Iphephile futhi Iyasebenza: Ukwenza kusebenze okumnene ukuze kunwetshwe amaseli aqinile
✔️ Kulula ukuyisebenzisa: Ifomethi elungele ukusetshenziswa
✔️ Kuyabiza: Ukusebenza okuthembekile namanani ancintisanayo

Izifo ze-autoimmune ziyinselelo yezempilo yomhlaba wonke, ethinta cishe u-10% wabantu. Kodwa kuthiwani uma ngikutshela ukuthi kukhona okungaba khona impumelelo ekwelapheni lezi zimo?

Siyajabula ukwabelana nge-webinar yethu yakamuva, "Understanding Autoimmune CAR-T Therapy," ehlanganisa noDkt. Allan Zhang. Kule seshini enokuqonda, uDkt. Zhang uhlola inqubekelaphambili yobuchwepheshe be-CAR-T kanye nokusebenza kwayo ezifweni ze-autoimmune, enikeza ithemba lokuxolelwa ngaphandle kwezidakamizwa.

Siyajabula ukumemezela ukuthi i-T&L Biotechnology izobamba iqhaza kuKhongolose Yaminyaka Yonke Yama-31 ye-ESGCT, umcimbi ophambili kwezokwelapha ngofuzo namaseli.

Ungaphuthelwa yileli thuba lokuba yingxenye yomcimbi wenguquko. Ukuze uthole ulwazi olwengeziwe noma ukumisa umhlangano, sicela usithinte ngokuqondile. Siyajabula ukukwamukela endaweni yethu futhi sixoxe ngokuthi i-T&L Biotechnology ingaba kanjani uzakwethu obalulekile ohambweni lwakho lwesayensi.

Sanibona eRoma!

Ukwelashwa ngamaseli kuthuthuke ngokushesha eminyakeni yamuva nje ocwaningweni nasekuthuthukisweni kwemithi, futhi kuyindlela entsha yokuthuthukisa izidakamizwa ebonise amandla amakhulu ekwelapheni izifo ezinjengomdlavuza, izifo ezithathelwanayo, nezifo ezizimele.

Muva nje, i-Beijing T&L Biotechnology Ltd. (ebizwa ngokuthi "T&L") ithole ngempumelelo ukubhaliswa kwe-US FDA DMF kwe-CGT core material yayo eluhlaza i-CD28 monoclonal antibody, enenombolo yokubhalisa ye-DMF 038820.

Muva nje, i-Beijing T&L Biotechnology Ltd. (ngemuva kwalokhu ebizwa ngokuthi "T&L") ithole incwadi yokuqinisekisa evela ku-US Food and Drug Administration (ngemuva kwalokhu ebizwa ngokuthi "FDA"), ithi izinto zokusetshenziswa eziyinhloko zenkampani zemithi yokwelapha amangqamuzana, i-CD3 monoclonal antibody, kanye nobuhlalu obuzibuthe bokuhluza i-T cell, kugcwalise ngokusemthethweni i-FDA yohlobo lwe-US II.